Pharma Blog Watch

Adverse Drug Reactions (Drug Injury Watch)
Continuing his series on adverse drug reactions, blogger Tom Lamb writes about drug-safety monitoring, including how a new collaboration between the FDA and the Massachusetts Institute of Technology to develop an automated system will be an improvement over MedWatch.

PDUFA Fees (Eye on FDA)
In his blog, Mark Senak discusses Prescription Drug User Fee Act (PDUFA) fees, which he believes will only continue to increase. "The current environment, colored by the post-Vioxx mentality, is likely to produce many more mandates," and more enforcement will require more funding, he writes.